Brief: China Resources Pharmaceutical Says FY Net Income RMB 8,403.2 Million
26/03/2025 04:32
March 26 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK: FY GROSS MARGIN 15.8% FY NET INCOME RMB 8,403.2 MILLION FY GROSS PROFIT RMB 40,688.9 MILLION FINAL DIVIDEND OF RMB0.052 PER ORDINARY SHARE FY REVENUE RMB 257,673.3 MILLION Further company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million